Skip to main content
SpringerLink
Log in

Familial isolated primary hyperparathyroidism due to HRPT2 mutation

  • Case report
  • Published:
Hormones Aims and scope Submit manuscript

Abstract

Primary hyperparathyroidism is a common endocrine disorder that is mostly caused by solitary tumors within the parathyroid glands. Characterized by early debut and higher frequency of multiple parathyroid masses, familial forms of primary hyperparathyroidism are caused by the already known mutations of: menin (MEN1 syndrome), RET proto-oncogene (MEN2 syndrome), HRPT2-parafibromin (hyperparathyroidism-jaw tumor syndrome), calcium sensing receptor gene (familial hypocalciuric hypercalcemia). A specific mutation in FIHP has not been identified in the majority of affected families. Recent studies revealed menin, HRPT2 and calcium-sensing receptor mutations in patients with FIHP. Whether FIHP is a variant or an early stage of MEN1 syndrome or hyperparathyroidism-jaw tumor syndrome is yet to be established. We present three siblings with familial isolated hyperparathyroidism due to solitary parathyroid adenoma and favorable evolution post-parathyroidectomy. Genetic tests revealed HRPT2 mutation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weimers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, 2006 Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21: 171–177.

    Article  Google Scholar 

  2. Brandi ML, Gagel RF, Angeli A, et al, 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671.

    Article  CAS  PubMed  Google Scholar 

  3. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ, 2005 Primary hyperparathyroidism: new concepts in clinical, densitometric, and biochemical features. J Int Med 257: 6–17.

    Article  CAS  Google Scholar 

  4. Gardner DG, Shoback D, 2007. In Greenspan’s Basic and Clinical Endocrinology, Chapter 23, McGraw Hill Medical.

  5. Larsson C, Skogseid B, Oberg K, et al, 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85–87.

    Article  CAS  PubMed  Google Scholar 

  6. Chandrasekharappa SC, Guru SC, Manickam P, et al, 1997 Positional cloning of the gene for multiple endocrine neoplasia-type I. Science 276: 404–407.

    Article  CAS  PubMed  Google Scholar 

  7. Agarwal SK, Guru SC, Heppner C, et al, 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96: 143–152.

    Article  CAS  PubMed  Google Scholar 

  8. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al, 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Nat Acad Sci USA 103: 15558–15563.

    Article  CAS  PubMed  Google Scholar 

  9. Simonds WF, James-Newton LA, Agarwal SK, et al, 2002 Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81: 1–26.

    Article  Google Scholar 

  10. Szabo J, Heath B, Hill VM, et al, 1995 Hereditary hyperparathyroidism-jaw-tumor syndrome: the endocrine-tumor gene HRPT2 maps to chromosome 1q21–q31. Am J Hum Genet 56: 944–950.

    PubMed  PubMed Central  CAS  Google Scholar 

  11. Simonds WF, James-Newton LA, Agarwal SK, et al, 2002 Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81: 1–26.

    Article  Google Scholar 

  12. Marx SJ, Simonds SF, Agarwal SK, et al, 2002 Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Min Res 17(suppl. 2): N37–43.

    CAS  Google Scholar 

  13. Larsson C, 2000 Dissecting the Genetics of Hyperparathyroidism—New Clues from an Old Friend, J Clin Endocrinol Metab 85: 1752–1754.

    PubMed  CAS  Google Scholar 

  14. Carpten JD, Robbins CM, Villablanca A, et al, 2002 HRPT2, encoding parafibromin, is mutated in HPT-jaw tumor syndrome. Nat Genet 32: 676–680.

    Article  CAS  PubMed  Google Scholar 

  15. Shattuck TM, Valimaki S, Obara T, et al, 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349: 1722–1729.

    Article  CAS  PubMed  Google Scholar 

  16. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ, 2004 Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89: 96–102.

    Article  CAS  PubMed  Google Scholar 

  17. Bradley KJ, Bowl MR, Williams SE, et al, 2007 Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26: 1213–1221.

    Article  CAS  PubMed  Google Scholar 

  18. Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF, 2007 Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function. Molecular Cancer Research: MCR 5: 183–193.

    Article  CAS  PubMed  Google Scholar 

  19. Yang YJ, Han JW, Youn HD, Cho EJ, 2010 The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Research 38: 382–390.

    Article  CAS  PubMed  Google Scholar 

  20. Woodard GE, Lin L, Zhang JH, et al, 2005 Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24: 1272–1276.

    Article  CAS  PubMed  Google Scholar 

  21. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, et al, 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25: 612–620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Chaudhary K, Deb S, Moniaux N, Ponnusamy MP, Batra SK, 2007 Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene 26: 7499–7507.

    Article  CAS  PubMed  Google Scholar 

  23. Farber LJ, Kort EJ, Wang P, Chen J, Teh BT, 2010 The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA. Mol Carcinog 49: 215–223.

    PubMed  CAS  Google Scholar 

  24. Pollak MR, Brown EM, Chou YH, et al, 1993 Mutations in the human Ca(2+) sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 75: 1297–1303.

    Article  CAS  PubMed  Google Scholar 

  25. Fuleihan GE, Brown EM, Heath HH III 2008 Familial benign hypocalciuric hypercalcemia and neonatal primary hyperparathyroidism. In: Principles of Bone Biology, Bilezikian JP, Raisz LG, Martin TJ, (eds) Academic Press, San Diego; pp, 1327–1345.

    Chapter  Google Scholar 

  26. Teh BT, Farnebo F, Twigg S, et al, 1998 Familial isolated hyperparathyroidism maps to the hyperparathyroidismjaw tumor locus in 1q21–q32 in a subset of families. J Clin Endocrinol Metab 83: 2114–2120.

    PubMed  CAS  Google Scholar 

  27. Cascón A, Huarte-Mendicoa CV, Javier Leandro-Garcia L, et al, 2011 Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosomes Cancer 50: 922–999.

    Article  CAS  PubMed  Google Scholar 

  28. Arnold A, 2008 Familial hyperparathyroidism. In: Rosen CJ, (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Washington, DC: American Society for Bone and Mineral Research, pp, 361–367.

    Chapter  Google Scholar 

  29. Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP, 2008 Parathyroid Carcinoma. J Bone Miner Res 23: 1869–1880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kassem M, Kruse TA, Wong F-K, et al, 2000 Familial isolated hyperparathyroidism—a variant of MEN1. J Clin Endocrinol Metab 85: 165–167.

    PubMed  CAS  Google Scholar 

  31. Pannett AA, Kennedy AM, Turner JJ, et al, 2003 Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) 58: 639–646.

    Article  CAS  Google Scholar 

  32. Thakker RV, 2006 Multiple Endocrine Neoplasia Type 1. In Endocrinology, DeGroot LJ, Jameson JL (eds) Philadelphia, PA: WB Saunders, pp, 3509–3531.

    Google Scholar 

  33. Hannan FM, Nesbit AM, Christie PT, et al, 2008 Familial Isolated Primary Hyperparathyroidism Caused by Mutations of the MEN1 Gene. Nat Clin Pract Endocrinol Metab 4: 53–58.

    Article  CAS  PubMed  Google Scholar 

  34. Pearce SH, Williamson C, Kifor O, et al, 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115–1122.

    Article  CAS  PubMed  Google Scholar 

  35. Motokura T, Bloom T, Kim HG, et al, 1991 A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512–515.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. “G.I. Parhon” National Institute of Endocrinology, Bd. Aviatorilor 34–36, sector 1, Bucharest, 011863, Romania

    Adina Ghemigian, Mircea Ghemigian, Irina Popescu, Nicoleta Dumitru & Dumitru Ioachim

  2. “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

    Adina Ghemigian, Lavinia Vija & Eugenia Petrova

Authors
  1. Adina Ghemigian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mircea Ghemigian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irina Popescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lavinia Vija
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eugenia Petrova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicoleta Dumitru
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dumitru Ioachim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adina Ghemigian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghemigian, A., Ghemigian, M., Popescu, I. et al. Familial isolated primary hyperparathyroidism due to HRPT2 mutation. Hormones 12, 454–460 (2013). https://doi.org/10.1007/BF03401311

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401311

Key words

Search

Navigation